ICON Builds China Presence by Acquiring BeijingWits, a Clinical CRO

ICON plc, a global CRO based in Ireland, made good on a promise to increase its China presence by acquiring a China clinical-stage CRO, BeijingWits Medical Consulting. Founded in 1997, BeijingWits offers Phase I-IV clinical trial services and claims expertise in China’s regulatory processes. ICON said the transaction would add 100 experienced personnel to its China staff. Terms were not disclosed. More details.... Stock Symbol: (NSDQ: ICLR)     Share this with colleagues: